/PKTX
PKTX Stock - ProtoKinetix, Incorporated
Healthcare|BiotechnologyOTC
$0.01+3.64%
+$0.00 (+3.64%) • Dec 19
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.11
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.98
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PKTX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.01
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.54
52W High$0.01
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-52,870 | $-48,259 | $-58,450 | $-3,000 | $-3,000 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-311,000 | $-367,000 | $-1,849,000 | $-2,329,000 | $-7,644,000 |
| Net Income | $-364,000 | $-415,000 | $-1,907,000 | $-2,329,000 | $-7,644,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.00 | $-0.01 | $-0.01 | $-0.01 | $-0.03 |
Company Overview
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PKTXBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q4 2025 | Nov 10, 2025 | — | — | — | — |
Q3 2025 | Jul 28, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 13, 2025 | — | $-0.00 | — | — |
Q1 2025 | Mar 28, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 12, 2024 | — | $-0.00 | — | — |
Q3 2024 | Jul 30, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 15, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 20, 2024 | — | $-0.00 | — | — |
Q4 2023 | Oct 18, 2023 | — | $-0.00 | — | — |
Q3 2023 | Jul 14, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 2, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 17, 2023 | — | $-0.00 | — | — |
Q4 2022 | Oct 31, 2022 | — | $-0.00 | — | — |
Q3 2022 | Jul 29, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 10, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 10, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 11, 2021 | — | $-0.00 | — | — |
Q3 2021 | Jul 28, 2021 | — | $-0.00 | — | — |
Q2 2021 | Apr 16, 2021 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PKTX
What is PKTX's current stock price?
ProtoKinetix, Incorporated (PKTX) is currently trading at $0.01 per share. The stock has moved +3.64% today.
What is the analyst price target for PKTX?
No analyst price targets are currently available for this stock.
What sector is ProtoKinetix, Incorporated in?
ProtoKinetix, Incorporated operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is PKTX's market cap?
ProtoKinetix, Incorporated has a market capitalization of $0.00 billion, making it a small-cap company.
Does PKTX pay dividends?
No, ProtoKinetix, Incorporated does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAGNPF
Algernon Pharmaceuticals Inc.
$0.06
Mkt Cap: $0.0B
ARUXF
Acrux Limited
$0.01
Mkt Cap: $0.0B
AXIM
AXIM Biotechnologies, Inc.
$0.02
Mkt Cap: $0.0B
HAVLF
HAVN Life Sciences Inc.
$0.00
Mkt Cap: $0.0B
IBOGF
Universal Ibogaine Inc.
$0.01
Mkt Cap: $0.0B
RDDTF
Radient Technologies Inc.
$0.00
Mkt Cap: $0.0B
REPCF
RepliCel Life Sciences Inc.
$0.00
Mkt Cap: $0.0B
RNUGF
ReNeuron Group plc
$0.00
Mkt Cap: $0.0B
SIGY
Sigyn Therapeutics, Inc.
$1.71
Mkt Cap: $0.0B
ZLDAF
Zelira Therapeutics Limited
$0.23
Mkt Cap: $0.0B
Explore stocks similar to PKTX for comparison